Raremark is privately owned and has raised funding from the following investors

AlbionVC is the technology investment arm of Albion Capital Group LLP. The technology team invests from seed through to Series B in high growth companies, predominantly in the UK, with a particular focus on B2B software and technology enabled services. Albion has 20+ years’ experience investing in technology, has c.£450m FUM in technology companies and over 40 tech investments within its portfolios. Visit:

Ananda Ventures is one of the leading venture capital investors for impact enterprises in Europe. Impact enterprises solve social challenges in sustainable, market-driven ways – tackling issues such as education, sustainable consumption, the ageing population and health. Ananda shares entrepreneurs’ passion for building outstanding companies in a professional, dynamic way. Visit:

The Cass Entrepreneurship Fund is a £10m venture capital fund, based at Cass Business School. The Fund makes commercial equity investments into high-potential, revenue-generating businesses. The Cass Entrepreneurship Fund was set up with the generous support of Peter Cullum, CBE, an alumnus of Cass, as part of a wider vision to improve practical business support and entrepreneurial skill-building within Cass Business School and across the early-stage growth-business community. Visit:

Oltre Venture uses the venture capital operating model, channelling economic resources towards the most innovative and efficient projects, and offering managerial and financial skills to entrepreneurs. Oltre invests in companies in social sectors, with a specific focus on healthcare, education, social housing, customer-oriented and social services, job placement and economic development of depressed geographic areas. The purpose of the companies in which Oltre invests is to develop new and better solutions to social and collective needs, with the aim of creating added value for customers and the entire community, other than for their shareholders. Visit:

Community contact

For patients & families

T +44 (0)20 7034 3216

Partnering contact

Julie Walters

T +44 (0) 20 7034 3216

M +44 (0) 775 362 6967

Media contacts

Pete Chan

T +44 (0) 20 7034 3216

M +44 (0) 775 328 0299